These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 19717018

  • 1. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.
    Lu LF, Yang SS, Wang CP, Hung WC, Yu TH, Chiu CA, Chung FM, Shin SJ, Lee YJ.
    J Stroke Cerebrovasc Dis; 2009; 18(5):354-9. PubMed ID: 19717018
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of plasma visfatin levels in patients with ischemic stroke.
    Yin CG, Jiang L, Tang B, Zhang H, Qian Q, Niu GZ.
    Peptides; 2013 Apr; 42():101-4. PubMed ID: 23328215
    [Abstract] [Full Text] [Related]

  • 3. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans.
    Liu SW, Qiao SB, Yuan JS, Liu DQ.
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):202-7. PubMed ID: 19178507
    [Abstract] [Full Text] [Related]

  • 4. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J, Witasp A, Carrero JJ, Qureshi AR, Suliman ME, Heimbürger O, Bárány P, Lindholm B, Alvestrand A, Schalling M, Nordfors L, Stenvinkel P.
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [Abstract] [Full Text] [Related]

  • 5. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC, Chang TJ, Lee WJ, Chuang LM.
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [Abstract] [Full Text] [Related]

  • 6. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD, Petrasch M, Rauh M, Stöhr W, Nüsken E, Schneider H, Dötsch J.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [Abstract] [Full Text] [Related]

  • 7. Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.
    Bo S, Ciccone G, Baldi I, Gambino R, Mandrile C, Durazzo M, Gentile L, Cassader M, Cavallo-Perin P, Pagano G.
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):423-30. PubMed ID: 19073361
    [Abstract] [Full Text] [Related]

  • 8. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
    Gen R, Akbay E, Muslu N, Sezer K, Cayan F.
    Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
    [Abstract] [Full Text] [Related]

  • 9. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH, Lee JK, Wang MC, Lu CC, Sun CC, Chuang MJ, Lam HC.
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [Abstract] [Full Text] [Related]

  • 10. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X, Ji Y, Chen J, Li S, Luo F.
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [Abstract] [Full Text] [Related]

  • 11. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Romero E.
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [Abstract] [Full Text] [Related]

  • 12. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF, Bahr MJ, Böker KH, Manns MP, Tietge UJ.
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [Abstract] [Full Text] [Related]

  • 13. Small dense low-density lipoproteins and associated risk factors in patients with stroke.
    Zhao CX, Cui YH, Fan Q, Wang PH, Hui R, Cianflone K, Wang DW.
    Cerebrovasc Dis; 2009 Feb; 27(1):99-104. PubMed ID: 19033685
    [Abstract] [Full Text] [Related]

  • 14. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y, Ebinç FA, Ebinç H, Paşaoğlu H, Demirtaş C, Taçoy G, Koç E, Derici U, Reis KA, Bali M, Arinsoy T, Sindel S.
    Ren Fail; 2008 Feb; 30(6):617-23. PubMed ID: 18661412
    [Abstract] [Full Text] [Related]

  • 15. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease.
    Moschen AR, Geiger S, Gerner R, Tilg H.
    Mutat Res; 2010 Aug 07; 690(1-2):95-101. PubMed ID: 19583971
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of the adipokine visfatin are increased in pre-eclampsia.
    Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H.
    Clin Endocrinol (Oxf); 2008 Jul 07; 69(1):69-73. PubMed ID: 18034779
    [Abstract] [Full Text] [Related]

  • 17. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA, Barakat YA.
    Saudi Med J; 2008 Feb 07; 29(2):185-92. PubMed ID: 18246224
    [Abstract] [Full Text] [Related]

  • 18. Visfatin and endothelial function in dialyzed patients.
    Malyszko J, Malyszko JS, Mysliwiec M.
    Nephrology (Carlton); 2010 Mar 07; 15(2):190-6. PubMed ID: 20470278
    [Abstract] [Full Text] [Related]

  • 19. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
    Caixàs A, Tirado R, Vendrell J, Gallart L, Megía A, Simón I, Llauradó G, González-Clemente JM, Giménez-Palop O.
    Clin Endocrinol (Oxf); 2009 Nov 07; 71(5):733-8. PubMed ID: 19222486
    [Abstract] [Full Text] [Related]

  • 20. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.
    Filippatos TD, Tsimihodimos V, Derdemezis CS, Gazi IF, Saougos V, Mikhailidis DP, Tselepis AD, Elisaf MS.
    Nutr Metab Cardiovasc Dis; 2013 Apr 07; 23(4):330-6. PubMed ID: 21963513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.